We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

Moreover, Alcon’s market share gains in the contact lens segment and upcoming product launches like PanOptix Pro and Unity are promising. Saxon also points to the forthcoming Capital Markets Day as a ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Alcon also saw headwinds in its vision care division due to declines in contact lens care in its international markets. The unit posted 7% sales growth, below a consensus of 8.5%. The company's New ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

US President Donald Trump has been lambasted by the medical community after suggesting research into whether coronavirus might be treated by injecting disinfectant into the body. He also appeared ...